NCT00339417View on ClinicalTrials.gov

Effect of Albendazole Dose on Clearance of Filarial Worms

PHASE2CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 22, 2006

Primary Completion Date

August 1, 2008

Study Completion Date

August 17, 2011

Conditions
Lymphatic Filariasis
Interventions
DRUG

Albendazole

DRUG

Ivermectin

Trial Locations (1)

Unknown

University of Bamako, Faculty of Medicine, Pharmacy and Odontostomatology, Bamako

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00339417 - Effect of Albendazole Dose on Clearance of Filarial Worms | Biotech Hunter | Biotech Hunter